# Sutter Health IRB – FDA Inspection, Apr 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/sutter-health-irb/1b7384c3-ac91-43c4-965c-8eb53ee0fb37
Source feed: FDA_Inspections

> FDA inspection 1094003 of Sutter Health IRB, April 25, 2019. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094003
- Company Name: Sutter Health IRB
- Inspection Date: 2019-04-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1279388 - 2025-08-08](https://www.keypedia.com/records/fda_inspections/sutter-health-irb/f223f9f0-7673-4970-9277-77abd97901ff)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/humberto-z-gomez/6de682f6-ae2a-45ff-92ab-ba6ac7bb97b4)

Company: https://www.keypedia.com/companies/sutter-health-irb/19f29ff1-d35c-478f-8c41-68aed6808391

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c